Paul Murray is Professor of Molecular Pathology in the School of Medicine, University of Limerick having joined from the University of Birmingham at the beginning of 2019.

Paul obtained his PhD in 1996 working on the contribution of the Epstein-Barr virus to the pathogenesis of Hodgkin lymphoma with Professor Lawrence Young at the University of Birmingham. He was a Fulbright Fellow in the Ambinder lab’ at the Johns Hopkins University, Baltimore, USA before setting up his own laboratory in  the Department of Pathology at the University of Birmingham in 2000. In 2007, he moved to the Institute of Cancer Studies, at the University of Birmingham, holding concurrent Cancer Research UK and Leukaemia Research Fund Programme grants as well as a number of project grants, including UK Medical Research Council awards. He has published 190 papers with an H-index of 69.

Research in the Murray Group is focused on the discovery of immune mechanisms involved in the development and progression of aggressive cancers derived from mature lymphocytes (the lymphomas) and more recently COVID-19.